The global fluoroscopy equipment market is estimated to grow at a CAGR of around 4% during the forecast period. The major factors contributing to the growth of the market include the rising incidence ad prevalence rate of chronic diseases and the rising demand for image-guided minimally invasive procedures. Real-time image guidance has been fundamental to the evolution of interventional radiology procedures. Image-guided therapy is an emerging field that is closely associated with minimally invasive procedures, robot-assisted surgery, and computer-assisted visualization. The real-time imaging allows the physicians to monitor the health progress of their patients. X-ray fluoroscopy has been the modality which is significantly used in cardiac catheterizations and vascular interventions. Fluoroscopy has emerged as the highly sophisticated technology with advanced 3D capabilities which can guide interventional procedures with less patient discomfort.

Several minimally invasive image-guided procedures have replaced highly invasive open surgical procedures. Owing to the considerable advances in the technology, smaller vessels, and more subtle contrast differences can be visualized in real-time, usually with low-radiation dose. Some of the major companies that are focusing on providing image-guided systems for interventional radiology procedures include Koninklijke Philips N.V. and Siemens Healthcare. Philips Healthcare offers BV Vectra mobile C-arm system for high-quality images that enables to offer excellent care. It is designed for orthopedic surgical procedures, such as spine, trauma and pain management.  Moreover, Siemens offers Artis Q.zen product range for interventional imaging. It is a visionary revolution in x-ray detection with unique sensitivity allowing ultra-low-dose imaging. Additionally, it offers exceptional performance owing to the new potential GIGALIX X-ray tube which is intended to offer high contrast resolution at any angle and patient size. It has applications in cardiology, image-guided surgery, and interventional radiology.

Increasing demand for image-guided minimally invasive procedures is the crucial factor encouraging the adoption of fluoroscopy equipment. The use of c-arm x-ray equipment in minimally invasive procedures can improve the efficiency of complex procedures as it provides real-time images that enable surgeons to accurately perform the procedure. Therefore, the advent of image-guided procedures is encouraging the growth of the market. Apart from these, several factors are restricting the market growth which include the stringent government regulations and significant radiation exposure which can disrupt and damage patients’ cells. However, the market is offering significant opportunity owing to the advances in fluoroscopy equipment and emerging demand for data-integrated imaging systems.

Segmentation

The global fluoroscopy equipment market is segmented based on type and application. Based on type, the market is classified into fixed and mobile. Based on application, the market is classified into cardiology, orthopedic, gastroenterology, urology and nephrology, and others.

Cardiology led a significant share in the application segment

Rising prevalence of CVD coupled with the increasing demand for image-guided cardiac procedures is primarily driving the demand for fluoroscopy equipment in cardiology application. For instance, as per the World Health Organization (WHO), globally, there were an estimated 422.7 million prevalent cases of CVD in 2015. The CVD incidences are estimated to grow significantly owing to the unhealthy lifestyle habits. As a result, the demand for diagnostic imaging techniques is anticipated to grow significantly to understand the exact cause of the condition which further enables physicians to recommend effective treatment. Fluoroscopic imaging technique has been primarily supporting the diagnosis and treatment of cardiac disorders, such as acute myocardial infarction, sudden cardiac arrest, and heart failure. For diagnostic imaging, it enables disease identification and assessing the patients who are at high risk. Additionally, it is used as a tool in image-guided interventional procedures for the treatment of structural heart disease, sudden cardiac arrest, congestive heart failure, ablation, atherosclerotic CVD and peripheral vascular disease/carotid artery stenosis.

Global Fluoroscopy Equipment Market Share by Application, 2018 (%)

[image]

Regional Outlook

The global fluoroscopy equipment market is segmented into four major regions, such as North America, Europe, Asia-Pacific, and RoW. Asia-Pacific is anticipated to witness optimistic growth during the forecast period owing to the increasing prevalence of chronic diseases coupled with the emerging demand for advanced medical imaging devices in the region. As per the World Heart Federation, non-communicable diseases (NCDs), including CVDs, are estimated to account for 87% of total adult deaths in China. Due to this rise in the prevalence of CVD and other chronic conditions, the providers of advanced diagnostic equipment are expanding their presence in these countries.

For instance, in January 2019, Agfa Wuxi Imaging Co., a part of Agfa-Gevaert Group has completed 30 years of its imaging activity in China. In 1988, the company has started its operations in China to offer state-of-the-art medical imaging technologies to the country’s hospitals and healthcare institutions. Moreover, in August 2018, Siemens AG introduced state-of-the-art diagnostics manufacturing facility in Gujarat, India. This facility is intended to conduct R&D for diagnostics products that can improve patient care. Therefore, this growing facility expansion in the Asia-Pacific countries to better serves their customers are supporting to increase the availability of this equipment in the region, which in turn, would likely to drive the market growth.

Global Fluoroscopy Equipment Market Growth, by Region 2019-2025

[image]

Market Players Outlook

The major players in the market include General Electric Co., Hologic, Inc., Koninklijke Philips N.V., Siemens Healthcare GmbH, and Canon Medical Systems Corp. The strategies followed by the market players to expand its market share and presence across geographies include partnerships and collaborations, mergers and acquisitions, product launches and geographical expansion. For instance, in February 2019, Koninklijke Philips N.V. introduced Zenition, a new mobile C-arm imaging platform. The platform brings together advances in image capture, image processing, versatility and ease of use pioneered on the company’s highly successful Azurion platform. It allows hospitals to leverage operating room (OR) performance to offer live image guidance for a broad range of procedures, such as orthopedic, trauma and vascular procedures. This will enable to increase precision during the procedure.

The Report Covers

• Market value data analysis of 2018 and forecast to 2025.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global fluoroscopy equipment market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.